Volpara is a leading provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer. Through recent acquisitions, the company has grown its US market share from 5% to 34% in the past five years. Further growth is predicted, with the US expected to mandate the early screening for breast cancer – a significant tailwind for Volpara’s prospects. Volpara’s tech and services are currently used in 35 countries and the company has expanded its footprint in the US$2.8 billion lung screen market.

NSX Limited owns the National Stock Exchange of Australia (NSX) – the country’s second-largest listing stock exchange and direct competitor to the ASX. It specialises in listing growth companies and has a combined market capitalisation in excess of $2.7 billion and averages more than $8 million in raised capital per offer. NSX offers Australia’s widest range of listing options covering all market sectors with advantages such as simple rules, early-stage listing, faster listing process, and lower costs. NSX offers a collaborative and customer-focused approach with principle-based rules that reduce the work required in the IPO process.

Praemium is a market leader in managed accounts, reporting, corporate actions, and tax management for SMSF investments and investment portfolios. Since 2001, Praemium has crafted and optimised their technology in collaboration with financial professionals to build the ideal next-generation platform used by almost 1,000 financial institutions. The company services in excess of 300,000 investor accounts covering over $170 billion in funds globally. The world’s leading financial advisers, investment managers, institutions, accountants and product providers use Praemium to manage or administer their investments.